Denali makes $275m funding agreement with Royalty Pharma
Completion of the agreement remains contingent on several closing conditions.
Drug Manufacturers
Takeda and Innovent fulfil close conditions for ADC and IO therapies
Made Scientific and Cellergy partner to advance CLG-001
Moderna to onshore drug product manufacturing to Massachusetts
CPHI 2025: ‘handprint’ metric bridges pharma sustainability and economic value
Chiesi and Aliada sign licence deal for enzyme replacement therapies
Novartis opens California site for RLT manufacturing
Abzena and Mabqi partner for drug development solution
